Beijing Kawin Technology Share-Holding Co Ltd
688687
Company Profile
Business description
Beijing Kawin Technology Share-Holding Co Ltd is a biotechnology company. It offers healthcare solutions for liver disease. The company's products include Pirfenidone Tablets, Peginterferon Alfacon-2 Injection, and Compound glycyrrhizin capsules.
Contact
No. 6, Rongjing East Street
Building 3, Beijing Economic and Technological Development Zone
Beijing100176
CHNT: +86 1067892271
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
600
Stocks News & Analysis
stocks
Market Minute: RBA cuts rates again, US CPI data released
This week, the RBA cut rates after a surprise hold in July; CBA reported earnings ; US inflation data came out, showing its highest reading since February.
stocks
Is the market still overlooking Alibaba’s AI potential?
Despite a 40% share price rally this year, investors could still be underestimating Alibaba’s cloud growth prospects.
stocks
ASX reporting season wrap: CBA, JB Hi-Fi, REA and more
A round up of notable stories and reactions as ASX earnings season gathers steam.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,212.10 | 63.00 | 0.69% |
| CAC 40 | 7,923.45 | 53.11 | 0.67% |
| DAX 40 | 24,359.30 | 18.20 | -0.07% |
| Dow JONES (US) | 45,005.80 | 94.54 | 0.21% |
| FTSE 100 | 9,138.90 | 38.34 | -0.42% |
| HKSE | 25,270.07 | 249.25 | -0.98% |
| NASDAQ | 21,613.89 | 96.78 | -0.45% |
| Nikkei 225 | 43,378.31 | 729.05 | 1.71% |
| NZX 50 Index | 12,889.38 | 55.30 | 0.43% |
| S&P 500 | 6,451.71 | 16.83 | -0.26% |
| S&P/ASX 200 | 8,938.60 | 64.80 | 0.73% |
| SSE Composite Index | 3,696.77 | 30.33 | 0.83% |